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Background: Protein-tyrosine phosphatase 1B (PTP1B) is a physiological regulator of insulin signaling and adiposity
and is a drug target for the treatment of obesity and diabetes. The molecular mechanisms underlying PTP1B
metabolic actions require additional investigation.
Results: Herein, we identify Munc18c as a novel PTP1B substrate in adipocytes and in vivo. We demonstrate
nutritional regulation of Munc18c in adipose tissue revealing decreased expression upon high fat feeding. In
addition, PTP1B deficiency leads to elevated Munc18c tyrosine phosphorylation and dissociation from syntaxin4. At
the molecular level, we identify Munc18c Tyr218/219 and Tyr521 as key residues that mediate Munc18c interaction
with PTP1B. Further, we uncover an essential role of Munc18c total tyrosine phosphorylation in general, and Tyr218/219
and Tyr521 in particular, in regulating its interactions and glucose uptake in adipocytes.
Conclusion: In conclusion, our findings identify PTP1B as the first known tyrosine phosphatase for Munc18c and a
regulator of its phosphorylation and function in adipocytes.
Keywords: PTP1B, Munc18c, SNARE complex, Adipocytes, GlucoseBackground
Glucose homeostasis is tightly controlled through the reg-
ulated balance of absorption from the intestine, produc-
tion from the liver and uptake by peripheral tissues. Most
postprandial glucose uptake in peripheral tissues occurs in
muscle and fat. Insulin-stimulated glucose uptake in these
tissues is mediated by translocation of vesicles containing
the glucose transporter GLUT4 from intracellular stores
to the cell periphery and subsequent fusion with the
plasma membrane (PM) resulting in the externalization of
GLUT4 [1,2]. Fusion of GLUT4 vesicles with the PM is
mediated by soluble N-ethylmaleimide-sensitive factor at-
tachment protein receptor (SNARE) complex that consists
of synaptosomal-associated protein (SNAP23), syntaxin4
and vesicle-associated membrane protein 2 (VAMP2)* Correspondence: fghaj@ucdavis.edu
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reproduction in any medium, provided the or[3-5]. SNARE complexes are strictly regulated to ensure
that trafficking occurs with precise spatial and temporal
coordinates.
Sec1/Munc18 (SM) proteins are essential regulators of
SNARE-mediated vesicle budding and fusion events. SM
proteins are conserved in Saccharomyces cerevisiae (Sec1),
Caenorhabditis elegans (Unc18) and mammalian systems
(Munc18). Mammalian cells express three isoforms (a, b
and c) of Munc18 from the SM protein family and are
largely localized to the PM [6,7]. Munc18-1 (also known
as Munc18a) is expressed predominantly in neuronal tis-
sues and plays an important role in neurotransmitter
release [8,9]. Munc18b and Munc18c are ubiquitously
expressed [7], though only Munc18c is implicated in the
regulation of GLUT4 translocation in adipocytes. 3T3-L1
adipocytes use solely the Munc18c-syntaxin4 pair to regu-
late insulin-stimulated GLUT4 vesicle exocytosis [10,11].
Studies of Munc18c overexpression in adipocytes or using
peptides that inhibit its binding to syntaxin4 reveal an in-
hibitory role of Munc18c in insulin-stimulated GLUT4
translocation to the PM [11-13]. In line with thesetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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exhibit increased sensitivity to insulin-stimulated GLUT4
externalization and suggest that Munc18c-syntaxin4
interaction should be disrupted for docking/fusion to
proceed [14]. Of note, Munc18c undergoes stimulus-
induced tyrosine phosphorylation at Tyr521 to dissociate
from syntaxin4 in 3T3-L1 adipocytes [15]. Moreover, the
insulin receptor (IR) was identified as a kinase that
phosphorylates Munc18c at Tyr521, thereby linking in-
sulin signaling directly to SNARE exocytosis [15,16].
Thus, tyrosine phosphorylation of Munc18c is a regula-
tor of its interactions and function; however, the phos-
phatase(s) that regulates Munc18c phosphorylation
remains unidentified.
Protein-tyrosine phosphatase 1B (PTP1B) is a ubiqui-
tously expressed non-receptor tyrosine-specific phos-
phatase that is localized on the cytoplasmic face of the
endoplasmic reticulum (ER) [17-19]. PTP1B is a physio-
logical regulator of glucose homeostasis and energy bal-
ance. Specifically, whole-body PTP1B knockout (KO)
mice are hypersensitive to insulin, lean and resistant to
high fat diet (HFD)-induced obesity [20,21]. Mice with
tissue specific PTP1B deletion in the liver and muscle
exhibit improved glucose homeostasis independent of
body weight [22-24], while mice with neuronal deletion
exhibit decreased body weight [25]. However, the role of
PTP1B in adipocytes is unresolved with studies demon-
strating detrimental or beneficial effects of adipose
PTP1B deficiency on body mass and insulin sensitivity
[25,26]. The salutary effects of PTP1B deficiency on
obesity and diabetes have focused attention on this
phosphatase as a potential therapeutic target. In this
study, we identify Munc18c as a novel PTP1B substrate
in adipocytes and demonstrate regulation of Munc18c
tyrosine phosphorylation and function by PTP1B.
Results
PTP1B regulates Munc18c tyrosine phosphorylation
The adipose tissue is a regulator of systemic glucose
homeostasis and energy balance [27]. There are two
major types of adipose tissues in mammals, white and
brown. White adipose tissue (WAT) is the main site
for triglyceride storage, whereas brown adipose tissue
(BAT) plays a role in the defense against cold and has
emerging anti-obesity properties [28,29]. To gain in-
sights into the molecular mechanisms underlying PT-
P1B metabolic actions, we utilized mass spectroscopy
and substrate-trapping to determine novel PTP1B sub-
strates in adipocytes [30]. These studies identified
known PTP1B substrates indicating the validity of the
approach but also uncovered several novel putative
substrates including Munc18c. Initially, we examined
Munc18c expression in differentiating adipocytes and
in adipose tissue depots. Immunoblots of Munc18c inbrown [31] and white (3T3-L1) adipose cell lines re-
vealed increased Munc18c expression upon adipocyte dif-
ferentiation (Figure 1A). In addition, we determined the
effect of high fat feeding on Munc18c expression in adi-
pose tissue depots. Mice were fed regular chow diet or
HFD and then sacrificed after 3, 7, and 11 weeks. Immu-
noblots revealed significant decrease in Munc18c expres-
sion in mice fed HFD compared with those fed regular
chow in all examined adipose depots (Figure 1B-G). Of
note, Munc18c cognate syntaxin, syntaxin4 demonstrated
comparable expression pattern increasing in adipocytes
during differentiation and decreasing in adipose tissue de-
pots upon high fat feeding (Figure 1). These findings dem-
onstrate regulated expression of Munc18c in adipose
tissue depots.
If Munc18c is a PTP1B substrate then PTP1B defi-
ciency should lead to increased Munc18c tyrosine
phopshorylation. To test this, we utilized PTP1B KO ad-
ipocytes [31] that are reconstituted with PTP1B wild type
(WT) or the substrate-trapping mutant D181A (D/A) that
retains substrate binding but is catalytically impaired [32].
Munc18c was immunoprecipitated from starved and
insulin-stimulated (10 minutes) KO, WT and D/A adipo-
cytes then immunoblotted using anti-phosphotyrosine
antibodies (Figure 2A). In line with previous studies
[15,33,34], insulin stimulation increased Munc18c tyrosine
phosphorylation in WT adipocytes. Importantly, basal and
insulin-stimulated Munc18c tyrosine phosphorylation was
significantly elevated in KO and D/A compared with WT
adipocytes. To evaluate if adipose PTP1B deficiency
in vivo modulates Munc18c tyrosine phosphorylation, we
determined Munc18c phosphorylation in the subcutane-
ous adipose depot of control (fl/fl) and adipose-specific
PTP1B KO mice. Insulin treatment led to increased
Munc18c tyrosine phosphorylation in WT mice compared
with basal (Figure 2B). Further, adipose-specific PTP1B
KO mice exhibited increased basal and insulin-stimulated
Munc18c tyrosine phosphorylation compared with control
mice (Figure 2B). Since Munc18c tyrosine phosphoryl-
ation disrupts its interaction with syntaxin4 [15,16,33,34],
we examined if PTP1B deficiency-induced increase in
Munc18c tyrosine phosphorylation results in attenuated
interaction with syntaxin4. To that end, Munc18c was
immunoprecipitated from starved and insulin-stimulated
WTand KO adipocytes then immunoblotted for syntaxin4
(Figure 2C). Indeed, insulin stimulation attenuated
Munc18c-syntaxin4 interaction in WT adipocytes com-
pared with basal. Further, basal and insulin-stimulated
Munc18c-syntaxin4 co-association was lower in KO com-
pared with WT adipocytes consistent with elevated
Munc18c phosphorylation in KO adipocytes. Together,
these data demonstrate that PTP1B deficiency in adipo-
cytes and in vivo leads to increased Munc18c tyrosine
phosphorylation.
Figure 1 (See legend on next page.)
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Figure 1 Munc18c expression in adipocytes and adipose tissue depots. A) Immunoblots of Munc18c, syntaxin4 and Tubulin in lysates of
brown and white (3T3-L1) adipocytes at different stages of differentiation. B-F) Immunoblots of Munc18c, syntaxin4 and Tubulin in lysates of
brown (BAT), subcutaneous (S.Q.), epididymal (Epi.), mesenchymal (Mes.), and retroperitoneal (Ret.) adipose depots of mice fed regular chow or
HFD for the indicated times. Each lane represents a sample from a separate animal. Bar graphs represent normalized data for Munc18c (G) and
syntaxin4 (H) expression normalized to Tubulin and presented as means ± SEM. (*; P ≤ 0.05, **; P≤ 0.01) indicate significant difference, in each
adipose depot, between all groups versus mice fed regular chow for 3 weeks, and (#; P ≤ 0.05, ##; P ≤ 0.01) indicate significant difference
between mice fed HFD for 7 and 11 weeks versus mice fed HFD for 3 weeks.
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The elevated Munc18c tyrosine phosphorylation upon
PTP1B deficiency promoted us to test whether Munc18c
is a direct substrate of PTP1B. Wild type PTP1B has a
high catalytic constant rendering its interaction with sub-
strates difficult to detect [35]. However, steady-state inter-
action of PTP1B with its substrates can be enhanced using
the substrate-trapping mutant that forms stable com-
plexes with tyrosine-phosphorylated substrates and has
been successfully utilized to identify PTP1B substrates
[19,32,36-38]. PTP1B was immunoprecipitated from KO
and D/A adipocytes and co-association with Munc18c
was determined. As expected, no association was detected
in KO adipocytes, but co-association was observed in D/A
adipocytes under basal conditions and was significantly
enhanced upon insulin stimulation (Figure 3A). To further
investigate the mechanism underlying Munc18c-PTP1B
interaction, we utilized lentiviral shRNA to generate
3T3-L1 preadipocytes with stable knockdown (KD) ofFigure 2 PTP1B regulates Munc18c tyrosine phosphorylation. A) Mun
and KO adipocytes reconstituted with PTP1B WT and D/A at basal and insu
phosphotyrosine and Munc18c. B) Munc18c was immunoprecipitated from
PTP1B KO fed HFD then immunoblotted using antibodies for phosphotyro
KO adipocytes and KO adipocytes reconstituted with WT at basal and insul
syntaxin4 and Munc18c. Bar graph represents normalized data presented a
insulin treated and non-treated cells, and (##; P ≤ 0.01) indicates significantMunc18c. Knockdown cells were reconstituted with wild
type Munc18c (R), and tyrosine (Y)-to-phenylalanine (F)
mutants Y218/219F and Y521F (Figure 3B). Munc18c
Tyr218/219 and Tyr521 sites were specifically evaluated
for several reasons: (a) these sites are conserved in many
species (Figure 3C), (b) both sites are identified biochem-
ically as important for Munc18c-syntaxin4 binding [34],
(c) Munc18c undergoes stimulus-induced tyrosine phos-
phorylation at Tyr219 in islet β-cells and Tyr521 in 3T3-
L1 adipocytes [15,33,34], (d) IR phosphorylates Munc18c
at Tyr521 in 3T3-L1 adipocytes [15,16], and (e) the amino
acid sequence flanking Tyr218/219 is similar to E/D-pY-
pY-R/K which has been reported as important for optimal
substrate recognition by PTP1B (but is not a requirement)
[39]. PTP1B WT and D/A were transiently expressed in
WT adipocytes and in adipocytes with Munc18c knock-
down reconstituted with Munc18c Y218/219F and Y521F
mutants, then co-association with Munc18c was deter-
mined (Figure 3D). We did not expect co-associationc18c was immunoprecipitated from lysates of PTP1B KO adipocytes
lin-stimulated conditions then immunoblotted using antibodies for
subcutaneous adipose tissue of control (fl/fl) and adipose-specific
sine and Munc18c. C) Munc18c was immunoprecipitated from PTP1B
in-stimulated conditions then immunoblotted using antibodies for
s means ± SEM. (**; P ≤ 0.01) indicates significant difference between
difference between WT and KO cells for the corresponding treatment.
Figure 3 Munc18c is a PTP1B substrate. A) PTP1B was immunoprecipitated from lysates of PTP1B KO adipocytes and KO adipocytes reconstituted
with PTP1B D/A at basal and insulin-stimulated conditions then immunoblotted using antibodies for Munc18c and PTP1B. B) Munc18c knockdown
(KD) cells were reconstituted with Munc18c wild type (R) and Y/F mutants (Y218/219F and Y521F). Lysates were immunoblotted for Munc18c and Erk1/2.
C) Sequences were aligned relative to amino acids Tyr218/219 and Tyr521 of mouse Munc18c. The boxed region denotes the location of amino acids
Tyr218/219 and Tyr521 across species. D) 3T3-L1 wild type (WT) and Munc18c knockdown cells (reconstituted with Y/F mutants) were transiently
transfected with PTP1B WT and D/A. PTP1B was immunoprecipitated using FG6 antibodies from starved and insulin-stimulated cells lysed in
NP40 or RIPA (R), resolved using SDS-PAGE then immunoblotted using antibodies for Munc18c and PTP1B. Bar graph represents Munc18c
levels in PTP1B immunoprecipitates normalized to level of PTP1B and presented as means ± SEM. (*; P ≤ 0.05, **; P ≤ 0.01) indicate significant
difference between insulin stimulated and non-stimulated cells, (#; P ≤ 0.05, ##; P ≤ 0.01) indicate significant difference between Munc18c Y/F
mutants and Munc18c WT insulin stimulated D/A cells, (&&; P ≤ 0.01) indicates significant difference between RIPA-treated and non-treated
insulin stimulated WT cells, and (^^; P ≤ 0.01) indicates significant difference between vanadate-treated and non-treated insulin stimulated
D/A cells.
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nature of the interaction. However, modest co-immu
noprecipitation was observed upon insulin stimulation
(Figure 3D), but is likely indirect and probably due to the
presence of both proteins in a large signaling complex. In-
deed, lysis of cells using the stringent lysis buffer RIPA (R)
disrupted PTP1B WT-Munc18c co-association (Figure 3D,
lane 3). As expected, no co-association was observed in
cells with PTP1B knockdown (Figure 3D, lanes 4, 5). Con-
sistent with the proposed hypothesis, co-association of en-
dogenous Munc18c and PTP1B D/A was detected under
basal conditions and was significantly enhanced upon in-
sulin stimulation (Figure 3D). Importantly, treatment with
pervanadate (V), a strong inhibitor of tyrosine phospha-
tases which oxidizes the essential cysteinyl residue in the
catalytic center of the enzymes [40], disrupted Munc18c-
PTP1B D/A interaction (Figure 3C, lane 8). This indicated
that the association is consistent with enzyme-substrateinteraction that is mediated by the active site cysteinyl
residue of PTP1B. Of note, Y218/219F and Y521F mutations
significantly attenuated Munc18c association with PTP1B
D/A (Figure 3C). Together, these data demonstrate that
Munc18c is a direct substrate of PTP1B and that Tyr218/
219 and Tyr521 are mediators of the association.
Munc18c tyrosine phosphorylation regulates its binding
to syntaxin4
We investigated the role of Munc18c total and Tyr218/219
and Tyr521 phosphorylation in Munc18c interactions
and the insulin-stimulated SNARE-mediated delivery of
GLUT4 to the plasma membrane. Initially, we determined
Munc18c total tyrosine phosphorylation in 3T3-L1 adipo-
cytes (WT) and in adipocytes with knockdown (KD) and
reconstituted expression of Munc18c (R, Y218/219F and
Y521F) under basal and insulin-stimulated conditions.
Munc18c was immunoprecipitated from NP-40 lysed
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using anti-phosphotyrosine antibodies (Figure 4A). WT
adipocytes exhibited a low but detectable level of
Munc18c tyrosine phosphorylation under basal conditions
and this was significantly increased upon insulin stimula-
tion. As expected, Munc18c phosphorylation was attenu-
ated in knockdown cells, while reconstitution with
Munc18c (R) restored phosphorylation to control (WT)
levels. Of note, Y218/219F and Y521F adipocytes exhibited
impaired insulin-stimulated Munc18c tyrosine phosphor-
ylation (Figure 4A). To further demonstrate regulation of
PTP1B/Munc18c co-association by tyrosine phosphoryl-
ation, Munc18c immunoprecipitates were immunoblotted
for PTP1B. In line with Munc18c tyrosine phosphoryl-
ation, insulin significantly enhanced Munc18c co-as
sociation with PTP1B and this was significantly attenuated
in Y218/219F and Y521F adipocytes (Figure 4A). Next, we
sought to determine the effects of Munc18c phosphoryl-
ation on its interactions with syntaxin4, so Munc18c im-
munoprecipitates were immunoblotted for syntaxin4. WT
and reconstituted (R) adipocytes exhibited robust associ-
ation of syntaxin4 and Munc18c under basal conditionsFigure 4 Tyrosine phosphorylation of Munc18c regulates its binding
lysates of wild type adipocytes and adipocytes with knockdown and reconsti
stimulated conditions, then immunoblotted using antibodies for phosphotyro
for tyrosine phosphorylated Munc18c/Munc18c and Syn4/Munc18c and prese
WT adipocytes and adipocytes with knockdown and reconstituted expression
conditions, then immunoblotted using antibodies for Munc18c, Glut4 and Syn
Syn4 and presented as means ± SEM. (*; P≤ 0.05, **; P≤ 0.01) indicate signific
(#; P≤ 0.05, ##; P≤ 0.01) indicate significant difference between different cellsand this was disrupted upon insulin stimulation in line
with increased Munc18c tyrosine phosphorylation. Inter-
estingly, whereas syntaxin4 associated with Munc18c
under basal conditions in Y218/219F and Y521F adipocytes,
it failed to dissociate upon insulin stimulation (Figure 4A).
Similar binding pattern was observed in reciprocal co-
immunoprecipitation experiments where syntaxin4 was
immunoprecipitated and binding of Munc18c determined
(Figure 4B). Importantly, dissociation of Munc18c from
syntaxin4 enables binding of GLUT4. Indeed, WT and
reconstituted (R) adipocytes exhibited robust insulin-
stimulated syntaxin4-GLUT4 association and this was
impaired in Y218/219F and Y521F adipocytes (Figure 4B). It
is important to note that syntaxin4-GLUT4 association is
in line with deoxyglucose uptake in these adipocytes
(see Figure 5C). Together, these findings establish an es-
sential role of tyrosine phosphorylation in general, and
Tyr218/219 and Tyr521 in particular, in regulating Munc
18c associations and demonstrate that insulin-induced
tyrosine phopshorylation triggers Munc18c dissociation
from syntaxin4 thereby facilitating SNARE-mediated
delivery of GLUT4 to the plasma membrane.to syntaxin4 and PTP1B. A) Munc18c was immunoprecipitated from
tuted expression of Munc18c (R and Y/F mutants) at basal and insulin-
sine, PTP1B, Syn4 and Munc18c. Bar graphs represent normalized data
nted as means ± SEM. B) Syn4 was immunoprecipitated from lysates of
of Munc18c (R and Y/F mutants) at basal and insulin-stimulated
4. Bar graphs represent normalized data for Munc18c/Syn4 and Glut4/
ant difference between insulin stimulated and non-stimulated cells, and
versus WT for the corresponding treatment.
Figure 5 Tyrosine phosphorylation of Munc18c regulates deoxy-glucose uptake. A) Immunoblots of GLUT4 in cytosol and membrane
fractions of differentiated WT adipocytes and adipocytes with knockdown (KD) and reconstituted expression of Munc18c (R and Y/F mutants) at
basal and insulin-stimulated conditions. Gels were also immunoblotted for GST and IRE1α to determine purity of the cytosol and membrane
fractions, respectively. B) Data are presented as mean ± SEM from four independent experiments. (*; P≤ 0.05, **; P≤ 0.01) indicate significant difference
between insulin stimulated and non-stimulated cells in cytosol and membrane fractions, (#; P≤ 0.05, ##; P≤ 0.01) indicate significant difference
between different cells versus WT for the corresponding treatement in the cytosol fraction, and (^; P≤ 0.05, ^^; P≤ 0.01) indicate significant difference
between different cells versus WT for the corresponding treatment in the membrane fraction. C) Basal and insulin-stimulated 2-deoxy-[3H] glucose
uptake was determined in differentiated WT adipocytes and adipocytes with KD and reconstituted expression of Munc18c at basal and insulin-
stimulated conditions. Data are presented as mean ± SEM from five independent experiments. (*; P≤ 0.05, **; P≤ 0.01) indicate significant difference
between the different cells versus WT at the corresponding treatment. Immunoblots of pAkt (T308 and S473) and Akt in lysates of differentiated WT
adipocytes and adipocytes with KD and reconstituted expression of Munc18c at basal and insulin-stimulated conditions.
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stimulated glucose uptake
To determine the functional requirements for Munc
18c total and site-specific tyrosine phosphorylation in
GLUT4 vesicle exocytosis, we evaluated GLUT4 subcel-
lular distribution and 2-deoxy-glucose uptake in differ-
entiated adipocytes. Differentiated Munc18c knockdown
and reconstituted adipocytes exhibited comparable tri-
glyceride content (determined using oil Red O staining;
data not shown) suggesting that Munc18c does not
significantly affect adipogenesis in vitro, in line withprevious observations [14]. Fractionation of adipocytes re-
vealed increased GLUT4 in membrane fraction of knock-
down compared with WT adipocytes (Figure 5A, B).
Notably, GLUT4 was significantly decreased in membrane
fraction of Y218/219F and Y521F adipocytes compared with
WT (Figure 5A, B). Further, we evaluated basal and
insulin-stimulated 2-deoxy-glucose uptake in adipocytes.
Insulin stimulation led to clear increase in glucose uptake
in control adipocytes (Figure 5C). Importantly, knockdown
adipocytes exhibited increased basal and insulin-stimulated
glucose uptake compared with WT. This finding is in line
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tivity to insulin-stimulated GLUT4 externalization in adi-
pocytes of Munc18c knockout mice [14]. In addition,
reconstituted (R) adipocytes exhibited comparable basal
and insulin-stimulated glucose uptake to WT adipocytes,
indicating that the observed effects in knockdown cells are
directly due to Munc18c deficiency. On the other hand,
basal and insulin-stimulated glucose uptake was attenuated
in Y218/219F adipocytes and exhibited a trend for attenu-
ation in Y521F adipocytes compared with WT (Figure 5C).
Finally, Akt activation (determined by phosphorylation at
T308 and S473) was comparable between adipocytes. To-
gether, these data demonstrate a requirement for Munc18c
tyrosine phosphorylation in insulin-stimulated glucose up-
take in adipocytes (Figure 6).
Discussion
Munc18 proteins are essential regulators of SNARE-
mediated vesicle budding and fusion events, and are
conserved from yeast to mammals. In this study, weFigure 6 Simplified schematic representation of GLUT4 traffic to the p
several molecules as they are delivered towards the cell periphery, then tet
with the plasma membrane as a complex is formed between VAMP2 on th
complex then facilitates the fusion of the GSV with the plasma membrane.
syntaxin4. The insulin receptor phosphorylates Munc18c at Tyr521 while PTP
signaling directly to SNARE exocytosis. Adapted from [46] with modificationdemonstrated nutritional regulation of Munc18c isoform
in adipose tissue in mice. In addition, we identified
Munc18c as a novel PTP1B substrate in adipocytes and
in vivo and uncovered Munc18c Tyr218/219 and Tyr521 as
key residues that mediate the association. Further, we
established an essential role of Munc18c tyrosine phos-
phorylation in general, and Tyr218/219 and Tyr521 in par-
ticular, in regulating Munc18c interactions and glucose
uptake in adipocytes. Together, these findings identify
PTP1B as the first known tyrosine phosphatase for
Munc18c and as an important regulator of its phosphor-
ylation and function in adipocytes.
Munc18c expression is regulated in the adipose tissue
and chronic high fat feeding in mice leads to decreased
Munc18c protein. Expression of the cognate syntaxin,
syntaxin4 is also decreased in adipose tissue upon high
fat feeding consistent with tight control of Munc18c/
syntaxin4 interaction and coordinate regulation of these
proteins. The current findings are in line with a recent
report demonstrating down regulation of Munc18clasma membrane. GLUT4 containing vesicles (GSVs) interact with
hered, docked and fused to the plasma membrane. The GSV docks
e vesicle and synatxin4 and SNAP23 on the plasma membrane. This
Tyrosine phosphorylation of Munc18c regulates its binding to
1B dephosphorylates Munc18c in adipocytes, thereby linking insulin
s.
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pose tissue depots of morbidly obese human subjects
[41]. It is not clear if decreased Munc18c expression in
overweight/obese rodents and humans is directly attrib-
uted to obesity or other factor(s) such as elevated
proinflammatory response to HFD. We speculate that
down regulation of Munc18c presents a mode of regu-
lation that may serve as a compensatory mechanism to
facilitate GLUT4 translocation and modulate insulin
action. Indeed, Munc18c expression decreases after
prolonged fasting in skeletal muscle of lean and obese
subjects concurrently with reduced insulin action [42].
Understanding the different tiers of Munc18c regula-
tion, such as expression and tyrosine phosphorylation
as presented herein, will yield insights into GLUT4
trafficking and possible modalities to increase glucose
transport.
Munc18c is a novel PTP1B substrate as evidenced by
several supporting observations. Mass spectrometry of
adipocytes expressing the substrate-trapping PTP1B mu-
tant identified Munc18c as a PTP1B-interacting protein.
In addition, adipocytes and adipose tissue lacking PTP1B
exhibited increased Munc18c tyrosine phosphorylation.
Moreover, substrate trapping demonstrated direct asso-
ciation between Munc18c and PTP1B D/A. Notably,
pervanadate treatment disrupted Munc18c-PTP1B D/A
association indicating that it is consistent with direct
enzyme-substrate interaction that is mediated by the
PTP1B active site. At the molecular level we identified
Munc18c Tyr218/219 and Tyr521 as key residues that me-
diate the association with PTP1B. It is important to note
that structurally these tyrosine residues are predicted to
be in close proximity [16]. In addition, Tyr521 is in the
disordered region of Munc18c that is notable for post-
translational modifications and conformation changes
[16]. Importantly, Tyr521 was recently identified as the
residue that is phosphorylated by IR upon insulin stimu-
lation [15,16]. Therefore, Munc18c tyrosine phosphoryl-
ation is regulated, at least in large part, by the opposing
actions of IR and PTP1B with precise spatial and tem-
poral coordinates. In one scenario, insulin stimulation
leads to IR activation and phosphorylation of Munc18c
Tyr521 allowing for signal propagation that is then
followed by dephosphorylation by PTP1B (Figure 6). In-
deed, insulin stimulation leads to reversible oxidation of
PTP1B at its active site and transient attenuation of its
enzymatic activity [43]. One function of insulin-induced
oxidation is transient inactivation of PTP1B, which usu-
ally exerts inhibitory constraint on the system, to initi-
ate a signaling response to the stimulus. It is important
to note that additional protein-tyrosine phosphatase(s)
may also regulate Munc18c phosphorylation. Further,
Munc18c is expressed in additional metabolic cells/tissues
such as pancreatic β-cells where PTP1B is also expressed[44], and additional studies are required to determine if
PTP1B regulates Munc18c (or other isoforms) in these
cells. At any rate, the current findings are the first to iden-
tify a protein-tyrosine phosphatase that directly regulates
Munc18c tyrosine phosphorylation and function in
adipocytes.
The current findings demonstrate that Munc18c tyro-
sine phosphorylation regulates its interactions and are
consistent with a functional requirement for Munc18c
phosphorylation in glucose uptake in adipocytes. Munc18c
tyrosine phosphorylation was elevated upon PTP1B defi-
ciency (in adipocytes and in vivo) leading to concomitant
decrease (~ 60%) in Munc18c-syntaxin4 association. Com-
parable attenuation of Munc18c-syntaxin4 association was
reported in adipocytes upon insulin stimulation [33] or
pervanadate treatment (i.e. PTP inhibition) [16]. In par-
ticular, mutants of the tyrosine residues (Tyr218/219 and
Tyr521) that mediate Munc18c-PTP1B interaction lacked
the ability to dissociate from syntaxin4 upon insulin
stimulation (Figure 4B) demonstrating the importance of
these tyrosines in regulating Munc18c interactions. Im-
portantly, we demonstrated that Munc18c association
with syntaxin4 is of functional significance. Munc18c defi-
ciency facilitated syntaxin4-GLUT4 interaction leading to
enhanced glucose uptake. On the other hand, Munc18c
mutants that did not dissociate from syntaxin4 disrupted
its binding to GLUT4 and consequently attenuated glu-
cose uptake. Together, our findings demonstrate an im-
portant role for PTP1B in regulating Munc18c tyrosine
phosphorylation and function. Presumably PTP1B can en-
gage different substrate(s) in adipocytes depending on the
nature of the stimulus, its magnitude and duration. Given
the salutary effects of PTP1B deficiency and inhibition in
obesity and diabetes additional studies are warranted to
fully elucidate the substrates and signaling mechanism
underlying its metabolic actions.Methods
Reagents
Dulbecco’s Modified Eagle Medium (DMEM), G418, peni-
cillin/streptomycin, puromycin, new born calf serum
(NBCS), fetal bovine serum (FBS) and trypsin were pur-
chased from Invitrogen (Carlsbad, CA). Antibodies for hu-
man PTP1B (FG6), mouse PTP1B, and Tubulin were
from Abcam (Cambridge, MA). Akt, phosphotyrosine
(PY99), syntaxin4, Glutathione-S-Transferase pi 1 (GST-
π1), IRE1α, and GLUT4 antibodies were from Santa Cruz
Biotechnology (Santa Cruz, CA). pAkt (Ser473) and pAkt
(Thr308) were from Cell Signaling Technology (Beverly,
MA). Munc18c antibodies were from Sigma (St. Louis,
MO) and phosphotyrosine (4G10) antibodies were from
Millipore (Billerica, MA). Horseradish peroxidase (HRP)-
conjugated secondary antibodies were from BioResources
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chemicals were purchased from Sigma.
Mouse studies
Male mice on C57Bl/6 J background (Jackson Labora-
tories) were maintained on a 12-hour light–dark cycle
and fed ad libitum. Mice were fed standard laboratory
chow (Purina lab chow, # 5001) at weaning or switched
to a HFD (60% kcal from fat, # D12492, Research Diets)
at 7 weeks of age. PTP1B-floxed (PTP1Bfl/fl) mice were
generated previously [25]. Adiponectin (Adipoq)-Cre
mice were obtained from Dr. E. Rosen (BIDMC/Harvard
University). Genotyping for the PTP1B floxed allele and
presence of Cre was performed by polymerase chain reac-
tion (PCR), using DNA extracted from tails [25,38]. At the
indicated age, mice were sacrificed and adipose depots
collected, frozen in liquid nitrogen then stored at −80°C.
Mouse studies were approved by Institutional Animal
Care and Use Committee at University of California Davis.
Cell culture
3T3-L1 cells were maintained in DMEM containing
25 mM glucose, 10% bovine calf serum (BCS), 50 U/ml
penicillin and 50 μg/ml streptomycin. Munc18c was si-
lenced in 3T3-L1 cells by testing five different hairpins
(Open Biosystems). Packaging (psPAX2) and envelope
(pMD2.G) vectors (Addgene, Boston) were co-transfected,
along with silencing hairpins into HEK293FT cells using
Lipofectamine 2000 (Invitrogen) following manufacturer’s
guidelines. Lentivirus was collected and used to infect
3T3-L1 cells. Cells were selected using puromycin
(2 μg/ml) and drug-resistant pools propagated. Cells
with knockdown (KD) of Munc18c were reconstituted
by transfection of wild type (WT) mouse Munc18c
(Origene) and Y/F (Y218/219F and Y521F) mutants. Stable
cell lines were maintained under 400 μg/ml G418 anti-
biotic selection for three weeks. To induce cell differenti-
ation, 3T3-L1 preadipocytes were grown to confluence in
culture medium containing 10% NBCS. Confluent cells
were then cultured in differentiation media containing
10% FBS, 20 nM insulin and 1 nM triiodothyronine
[T3] for 48 h. Adipocyte differentiation was induced by
treating cells for 48 h in differentiation medium further
supplemented with 0.5 μM dexamethasone, 0.5 mM
isobutylmethylxanthine, and 0.125 mM indomethacin
(induction media). After induction, cells were cultured
in differentiation medium until they exhibited a differ-
entiated phenotype with massive accumulation of fat
droplets.
Biochemical analyses
Tissues and cells were lysed in radio-immunoprecipitation
assay buffer (RIPA: 10 mM Tris–HCl, pH 7.4, 150 mM
NaCl, 0.1% sodium dodecyl sulfate [SDS], 1% Triton X-100,1% sodium deoxycholate, 5 mM EDTA, 1 mM NaF,
1 mM sodium orthovanadate and protease inhibitors).
Lysates were clarified by centrifugation at 13,000 rpm
for 10 min, and protein concentrations were deter-
mined using a bicinchoninic acid assay kit (Pierce Chem-
ical). For substrate-trapping experiments, cells were lysed
in 1% NP40 buffer with a protease inhibitor cocktail (with-
out sodium orthovanadate). Proteins (500 μg) were
immunoprecipitated with Munc18c or FG6 antibodies
and immune complexes were collected on protein G-
Sepharose beads (GE Healthcare) and washed with
lysis buffer. Proteins were resolved by SDS-PAGE and
transferred to PVDF membranes. Immunoblots were
performed using phosphotyrosine (4G10/PY99), FG6,
and Munc18c antibodies. Proteins were detected using
enhanced chemiluminescence (Amersham Biosciences).
Resulting immunoreactive bands were quantified using
FluorChem Q Imaging software (Alpha Innotech).
For site-directed mutagenesis, tyrosine (Y) to phenyl-
alanine (F) mutations in mouse Munc18c cDNA (origene)
were generated using a QuikChange Lightning Site-
Directed Mutagenesis Kit (Stratagene, La Jolla, CA) fol-
lowing the manufacturer instructions and confirmed by
DNA sequence analysis.
Subcellular fractionation
Subcellular fractions were isolated as previously described
[45] with modifications. Briefly, differentiated adipocytes
were washed in buffer 1 (100 mM sucrose, 1 mM EGTA,
20 mM MOPS, pH 7.4) and resuspended in buffer 2
(100 mM sucrose, 1 mM EGTA, 20 mM MOPS, 1% Tri-
ton X-100, 5% Percoll, 0.01% digitonin, 2 mM sodium
orthovanadate, 10 mM aprotinin, 10 mM pepstatin A,
10 mM leupeptin, 25 mM calpain inhibitor I and 1 mM
PMSF, pH 7.4). Cells were passed through a 30-gauge
syringe and incubated for 15 min on ice, unbroken
cells, mitochondria and nuclei were pelleted by centri-
fugation at 15,000 g. The supernatant was centrifuged
at 100,000 g for 1 h. The resulting supernatant and pellet
were designated as the cytosol and membrane fractions,
respectively and membrane fractions were resuspended in
RIPA buffer.
Deoxy-glucose uptake assay
Glucose uptake was determined as previously described
[31]. Briefly, differentiated 3T3-L1 adipocytes were treated
with insulin for 30 minutes after which 2-deoxy-[3H]
glucose (0.5 μCi/ml, final concentration) was added for
additional 3 minutes. The incorporated radioactivity was
quantitated using liquid scintillation counting.
Statistical analyses
Data are expressed as means ± standard error of the
mean (SEM). Statistical analyses were performed using
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http://www.biosignaling.com/content/11/1/57JMP program (SAS Institute). Comparisons between
groups were performed using unpaired two-tailed
Student’s t-test. A symbol (such as *) indicates P ≤ 0.05,
whereas a duplicate symbol (such as **) indicates P ≤ 0.01.
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